Your browser doesn't support javascript.
loading
Proposed selection strategy of surrogate matrix to quantify endogenous substances by Japan Bioanalysis Forum DG2015-15.
Wakamatsu, Akira; Ochiai, Shoko; Suzuki, Eiko; Yokota, Yoshinobu; Ochiai, Midori; Kotani, Yosuke; Sasahara, Satomi; Nakanaga, Keita; Hashimoto, Yuki; Ueno, Satoko; Kato, Nozomu; Kawada, Satoshi; Hayakawa, Jun; Shimada, Eiichi; Horita, Shinya; Sakai, Kazuaki.
Afiliação
  • Wakamatsu A; Bioanalysis, Immunogenicity & Biomarkers, Pre-Clinical Development Department, GlaxoSmithKline K.K. Akasaka Intersity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo 107-0052, Japan.
  • Ochiai S; Preclinical Research Unit, Drug Research Division, Sumitomo Dainippon Pharma Co., Ltd, 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.
  • Suzuki E; Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd, 1-2-58, Hiramachi, Shinagawa-ku, Tokyo 140-8710, Japan.
  • Yokota Y; Ligand Binding, Analytical Biology, SNBL USA, Ltd, 6605 Merrill Creek Parkway, Everett, WA 98203, USA.
  • Ochiai M; Development Management Department, Research & Development Division, Towa Pharmaceutical Co., Ltd, 2-5-15, Hiyoshi-cho, Moriguchi, Osaka 570-0081, Japan.
  • Kotani Y; Research Unit 2, Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Ltd, 16-1, Minami-Akasaka, Kainan, Wakayama 642-0017, Japan.
  • Sasahara S; Medicines Evaluation Team, Scientific Research and Business Development Department, Towa Pharmaceutical Co., Ltd, Kyoto Research Park KISTIC #202, 134, Chudoji Minami-machi, Shimogyo-ku, Kyoto, Kyoto 600-8813, Japan.
  • Nakanaga K; Toxicology and Pharmacokinetics Laboratories, Pharmaceutical Research Laboratories, Toray Industries, Inc., 10-1, Tebiro 6-chome, Kamakura, Kanagawa 248-8555, Japan.
  • Hashimoto Y; Bioanalysis Group, Osaka Laboratory, Technical Solution Headquarters, Sumika Chemical Analysis Service, Ltd, 1-135, Kasugade-Naka 3-chome, Konohana-ku, Osaka 554-0022, Japan.
  • Ueno S; Advanced Analytical Sciences Group, Fundamental Technology Labs., Institute For Innovation, Ajinomoto Co., Inc. 1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-8681, Japan.
  • Kato N; Discovery Technology Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 2-2-50, Kawagihi, Toda-shi, Saitama 335-8505, Japan.
  • Kawada S; Research Unit 1, Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Ltd, 16-1, Minami-Akasaka, Kainan, Wakayama 642-0017, Japan.
  • Hayakawa J; Biomarker R&D Department, Shionogi & Co., Ltd, 1-1, Futaba-cho 3-chome Toyonaka, Osaka 561-0825, Japan.
  • Shimada E; Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd, 17-2 Wadai Tsukuba-shi, Ibaraki 300-4247, Japan.
  • Horita S; Pharamacokinetics Research Laboratories, Translational Research Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd, 1188, Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, Japan.
  • Sakai K; DMPK Research Department, Teijin Institute for Bio-medical Research, Teijin Pharma Ltd 4-3-2 Asahigaoka, Hino, Tokyo 191-8512, Japan.
Bioanalysis ; 10(17): 1349-1360, 2018 Sep 01.
Article em En | MEDLINE | ID: mdl-30182726
It is important to select an appropriate surrogate matrix for preparing calibration standards and quality control samples while quantitatively assaying for endogenous substances, because a blank matrix that does not contain the endogenous substance cannot be derived from the species from which the target study samples are collected. This is because the assay results might be affected, depending on the characteristics of the analyte in the surrogate matrix. Our discussion group that participated in the Japan Bioanalysis Forum discussed the recommended selection strategies, focusing on large and small molecules in ligand binding assays and LC-MS, respectively. We established an efficient selection strategy for a surrogate matrix, with simple compositions as the first candidates stated in this article.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Química Analítica País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Química Analítica País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article